Compliance

Overview: Membership Meeting 2019

The membership of AAHP came together on March 8 for the association’s semiannual Membership Meeting. Taking place during Natural Products Expo West in Anaheim, Calif., AAHP members convened to hear updates on projects and initiatives, network, and elect new leadership before hitting the tradeshow floor. Three-Pronged Strategic Approach for 2019 readm more…

Read More

Reduce Risk with Product Substantiation

Susan J. Hewling   When bringing products to market, it is essential to build a platform that allows all information generated to be available for future use,” advised Susan J. Hewlings, PhD, RD, during a preview for her workshop this June at the AAHP Summit in Baltimore. Guest speaker at readm more…

Read More

Why Pharmacovigilance Matters

By Mark Land, AAHP President Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem.1 Serious adverse events for non-prescription drugs including homeopathic drug products have been required to be reported to FDA since 2007.2  Today readm more…

Read More

The Homeopathic Pharmacopeia of India

By Eric L. Foxman A quick look at its structure and contents, as well as the potential for adulteration and misbranding in the U.S. market. Structure The Homeopathic Pharmacopeia of India (HPI) is published by the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH). The Ministry is readm more…

Read More

Nux vomica: A Clinical Snapshot

By Todd A. Hoover, MD “Geez Doc! I’ve been sitting in the waiting room for 10 minutes. I need to get out of here to make my ten o’clock appointment. You really need to get better about staying on time.” I respond, “Yeah, I know, but my last patient had readm more…

Read More

2018 Enforcement Report for Labelers of Homeopathic Drug Products

Mark Land, AAHP President The most recent year (2018) has been a busy regulatory enforcement period for manufacturers and marketers of homeopathic drug products. Review of the Food and Drug Administration’s (FDA) website reveals enforcement actions against homeopathic products at multiple levels including inspections, warning letters, and recalls. The data readm more…

Read More

Outlook 2019: A Letter from the Board

By AAHP Board of Directors 2019 presents a unique crossroad to the homeopathic industry. As consumer demand for our products rises across North America, so does industry growth—and it is poised to continue growing. With this increased visibility comes increased scrutiny from regulatory bodies and potentially unfriendly consumer groups. While readm more…

Read More

Accelerating into the New Year

By Mark Land, AAHP President   As the homeopathic industry continues to grow, AAHP recognizes the need for constant improvement. This year, building on the momentum we gained in 2018, we plan to accelerate our efforts in the areas of advocacy, education, and outreach. All of our efforts aim to readm more…

Read More

How to Use Ignatia amara

(Image: Steven Edward/Flickr) By Todd A. Hoover, MD, DHt The homeopathic medicine Ignatia amara is derived from the St. Ignatius Bean (from the Strychnos ignatii plant). The tree is in the Loganiaceae family, and considered native to the Philippines and was naturalized into parts of China. The plant was first readm more…

Read More

The French Pharmacopeia

By Eric Foxman, R.Ph., AAHP Secretary A quick look at its structure and contents as well as two key considerations for potential adulteration and misbranding in the U.S. market. Structure The French Pharmacopeia (FP) is a publication of the National Agency for the Safety of Medicines and Health Products (ANSM), readm more…

Read More